Saturday 27 october 2018
1st Session : Antimicrobial Resistances
H. TALI-MAAMAR
H. ZIANE
Multiresistant Bacterial Infections: About 41 cases.
N. BOULAKEHAL
2nd Seance
H. ZIANE
Increased resistance to clarithromycin Helicobacterpylori in Algiers.
N. RAAF
Phenotypic and genotypic antibiotic-resistance in Campylobacter isolated from humans.
H. AMIR LAIDOUCI
Antibiotic resistance : Our role in emergence and intervention.
M. A. ALY
2nd Day : Sunday 28 october 2018
Message of Michel SIDIBE Executive Director UNAIDS.HIV on MENA Region.
A. ZEDDAM
B. BEGHDADLI
Mother-to-child transmission prevention of HIV: A two years study.
A. AIT ALI SLIMANE
B.
Evaluation of primary and acquired resistance to HIV-1 in infected Algerian patients.S. BOUZEGHOUB
4th Seance
Antiretrovirals and rapid weight gain in people living with HIV.
S. BESTAOUI
N. HEROUAL
Sunday 28 october 2018 Afternoon
3rd Session: Viral Hepatitis
5th Séance
Initial assessment of patients with positive HCV serology
W. GUENIFI
Evaluation of the sofosbuvir-ledipasvir combination in patients infected with HCV genotype1
A. TOUAREF
A. ELHASSI
Z. FALL MALICK
HCV eradication therapy changing pattern of liver disease in Egypt
A. El RAY
6th Seance
Viro-epidemiological situation of chronic viral hepatitis B and delta in northern Algeria
F. KHELIFA
The prognosis and managment of HBc Ag negative chronic infection
A. LETAIEF
N. GUESSAB
O. DRIR
Infection with the hepatitis delta virus (HDV) in Algeria and the Arab world
A. GASMI
3rd Day : Monday 29 october 2018
4th Session : Emerging and Re -emerging Infections
7th Seance
Inventory of the emerging and reemerging infectious diseases agents vectorized in Algeria
I. BITAM
I. LAFRI
Malaria in Tamanrasset 2012-2017
E. AKHAMOUK
S. BENSEGHIER
8th Seance
Mobile laboratory and its contribution in the containment of emerging pathologies.
M. KELLY
Algeria to the test of emerging diseases.
R. AIT HAMOUDA
12h00 - 12h15